Authors
Brenda Kischkel, Tristan Pascart, Nicholas Sumpter, Gwénaëlle Jayat, Nils Asmann, Charles Leroy, Augustin Latourte, Tim L Jansen, Mihai G Netea, Pascal Richette, Leo A B Joosten, Hang Korng Ea
Published in
Annals of the rheumatic diseases. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Gout and calcium pyrophosphate deposition (CPPD) disease cause clinically similar flares and are treated with largely overlapping drugs, yet their systemic inflammatory responses have rarely been compared directly in patients. We compared the circulating inflammatory proteome of both diseases during flares and over time in gout to investigate how these mediators evolve after flare resolution.
Proximity extension assay measured 92 inflammation-related proteins in plasma from 71 gout and 86 patients with CPPD during flares, and 96 middle-aged controls. Candidate biomarkers were validated in synovial fluid, crystal-stimulated peripheral blood mononuclear cells (PBMCs) and whole blood, murine air pouch model, and an independent gout cohort.
Gout and CPPD flare proteomes were similar, with increased TNFSF14 (false discovery rate [FDR] = 1.49-24), interleukin 6 (FDR = 4.93-36), transforming growth factor-α (FDR = 2.18-23), and colony stimulating factor-1 (FDR = 1.58-20) vs controls. Tumor necrosis factor superfamily member 14 (TNFSF14), previously validated in gout, was detected in CPPD synovial fluid and calcium pyrophosphate (CPP)-stimulated air pouch tissue. In contrast, caspase-8 (CASP-8) was higher in gout than in CPPD during flare (FDR = 7.57 × 10-12). Both monosodium urate and CPP crystals induced CASP-8 in PBMCs and whole blood, whereas CASP-8 inhibition attenuated crystal-induced immune responses. Longitudinally, CASP-8 remained elevated during the intercritical phase and after serum urate target was achieved, showing that its elevation in gout was not flare-restricted. Other persistently altered proteins were enriched in Mitogen-Activated Protein Kinases, tumor necrosis factor, and responses to endogenous stimuli, whereas flare-responsive proteins decreased after flare. Higher CASP-8 was moderately associated with impaired kidney function.
TNFSF14 is a candidate shared therapeutic target. CASP-8 distinguished gout from CPPD during flares, whereas its persistence across gout stages supports a broader role in sustained low-grade inflammation.
PMID:
43039800
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0